Choosing the right biologic treatment for individual patients with severe asthma - Lessons learnt from Picasso.

Abstract excerpt

Severe asthma represents a true challenge for clinicians from two basic perspectives, i.e.: a rational assessment of the underlying endo/phenotype and the subsequent selection of the best fitted (personalized) and effective treatment. Even though asthma is a heterogeneous disease, in the majority of therapy-compliant patients, it is possible to achieve (almost) complete disease control or even remission through...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Asthmatic Agents
• Share to Antibodies, Monoclonal, Humanized